Stevens-Johnson syndrome causes: Difference between revisions

Jump to navigation Jump to search
Line 20: Line 20:
**[[Cefadroxil]]
**[[Cefadroxil]]
**[[Cefotaxime sodium]]
**[[Cefotaxime sodium]]
**[[Cefotetan disodium]]
**[[Ceftazidime]]
**[[Ceftazidime]]
**[[Clobazam]]
**[[Clobazam]]
Line 53: Line 52:
*Drug side effects:
*Drug side effects:
**[[Cefaclor]]
**[[Cefaclor]]
**[[Cefotetan disodium]]
**[[Dactinomycin]]
**[[Dactinomycin]]
**[[Doripenem]]
**[[Doripenem]]

Revision as of 14:58, 9 February 2015

Stevens-Johnson syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stevens-Johnson Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stevens-Johnson syndrome causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stevens-Johnson syndrome causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stevens-Johnson syndrome causes

CDC on Stevens-Johnson syndrome causes

Stevens-Johnson syndrome causes in the news

Blogs on Stevens-Johnson syndrome causes

Directions to Hospitals Treating Stevens-Johnson syndrome

Risk calculators and risk factors for Stevens-Johnson syndrome causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Causes

References

  1. Medsafe Data Sheet March 8, 2005. Accessed April 26, 2007.
  2. Raksha MP, Marfatia YS (2008). "Clinical study of cutaneous drug eruptions in 200 patients". Indian J Dermatol Venereol Leprol. 74 (1): 80. PMID 18193504.
  3. Fagot J, Mockenhaupt M, Bouwes-Bavinck J, Naldi L, Viboud C, Roujeau J (2001). "Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis". AIDS. 15 (14): 1843–8. doi:10.1097/00002030-200109280-00014. PMID 11579247.
  4. Devi K, George S, Criton S, Suja V, Sridevi P (2005). "Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years". Indian J Dermatol Venereol Leprol. 71 (5): 325–8. PMID 16394456.
  5. Stevens-Johnson Syndrome-emerg/555 at eMedicine


Template:WikiDoc Sources